EN | UA
EN | UA

Help Support

Back

AASLD Guidance on Palliative Care for Patients with Decompensated Cirrhosis

AASLD Guidance AASLD Guidance
AASLD Guidance AASLD Guidance

In recent times, a rising prevalence of chronic liver disease has been witnessed. Chronic liver disease is defined as progressive worsening of hepatic functions for greater than 6 months.

See All

Attachment
Previous

Next
Ursodeoxycholic acid as prophylactic agent for gallstones and cholecystectomy: A meta-analysis

Comments (0)

Recommendations

Read
Watch

Russia’s N protein-based vaccine emerges as strong contender in g...

Can tocotrienol-rich vitamin E improve NAFLD in obese children?

COVID-19 and GI symptoms: Is H. pylori infection the missing link...

Read- How poor antibiotic knowledge fuels unnecessary demand in p...

Efficacy and safety of nonsteroidal anti-inflammatory drugs in As...

An introduction to pain pathways and mechanisms

Thank you for your participation!

Association between pain, central sensitization and anxiety in po...

Related Content

AASLD Guidance on Palliative Care for Patients with Decompensated...

Related Tags

XX

Next

482
Summaries

Ursodeoxycholic acid as prophylactic agent for gallstones and cho...

A systematic review and meta-analysis aimed to compare the occurrence of gallstone development, subsequent biliary illness, and requirement for c...

3 min More details
You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru ua
Try:

This website uses cookies to help us give you the best experience when you visit.

By using this website you consent to our use of cookies. For more information please review our cookie policy.